Improving Adherence to Homework During Therapy
Adherely STTR
Improving Adherence to Evidence-Based Practice Using an Innovative and Easy-to-Use Health IT Solution
2 other identifiers
interventional
79
1 country
1
Brief Summary
The purpose of this study is to expand Adhere.ly- a simple, HIPAA-compliant, web-based platform to help therapists engage clients in practicing therapeutic skills between sessions (homework) during mental health treatment by conducting a trial comparing standard therapy to therapy enhanced with Adhere.ly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable anxiety
Started Sep 2022
Typical duration for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
May 10, 2023
CompletedFirst Posted
Study publicly available on registry
May 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 29, 2024
CompletedResults Posted
Study results publicly available
January 15, 2026
CompletedJanuary 15, 2026
December 1, 2025
1.7 years
May 10, 2023
May 22, 2025
December 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Generalized Anxiety Disorder-7 (Gad-7)
The Generalized Anxiety Disorder Scale-7 (GAD-7) assesses the severity of anxiety symptoms in adults. The GAD-7 was completed by clients about themselves. Scores range from 0 to 21 with higher scores indicating worse anxiety symptom severity. A score of 8 or greater is generally considered to indicate clinically significant anxiety symptom severity.
Baseline, 3 Months Post Baseline
Patient Health Questionnaire-8 (PHQ-8)
The Patient Health Questionnaire-8 (PHQ-8) assesses the severity of depression symptoms in adults. The PHQ-8 was completed by clients about themselves. Scores range from 0 to 28 with higher scores indicating worse depression symptom severity. A score of 10 or greater is generally considered to indicate clinically significant depression symptom severity.
Baseline, 3 Months Post Baseline
Secondary Outcomes (8)
Health-Related Quality of Life (HRQOL-14) - Healthy Mental Health Days Index
Baseline, 3 Months Post Baseline
Homework Rating Scale II (HRS II)
Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 7, Week 8, Week 9, Week 10, Week 11, Week 12, Average across weeks reported.
Assessment of Core CBT Skills (ACCS) - Cognitive Behavioral Therapy Domain
Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 7, Week 8, Week 9, Week 10, Week 11, Week 12, Average across weeks reported.
Attitudes Toward Homework Questionnaire (ATHQ) - Positive Homework Effect Scale
Baseline, Post-Trial Therapist Assessment
Working Alliance Inventory - Short Revised (WAI-SR)
3 Months Post Baseline
- +3 more secondary outcomes
Study Arms (2)
Therapy
ACTIVE COMPARATORStandard regular therapy.
Therapy + Adhere.ly
EXPERIMENTALStandard regular therapy, enhanced with Adhere.ly
Interventions
The standard of care procedures for adults with clinically elevated anxiety and/or depression from their mental health provider.
Participants receive therapy as usual enhanced with a simple, HIPAA-compliant, web-based application to help mental health providers implement homework during therapy for adults with elevated anxiety and/or depression. The three major components of the app help providers to (1) Practice interactive, digitized therapeutic exercises with patients in-session; (2) Remind patients to practice exercises for homework, and (3) Review homework during the next session.
Eligibility Criteria
You may qualify if:
- Providers:
- English-speaking
- Mental health providers who have obtained at least a master's degree in social work, counseling, clinical psychology, or related field
- Carry active mental health treatment caseloads in the U.S.
- Have a laptop, tablet, or smartphone with internet access
- Clients:
- English-speaking
- Treatment-seeking adults ≥18 years
- Clinically elevated anxiety and depression as indicated by a score ≥10 on the GAD-7 and/or PHQ-8
- Have a laptop, tablet, or smartphone with internet access
You may not qualify if:
- Client with self-reported:
- Active psychotic symptoms (e.g., hallucinations, delusions)
- Significant cognitive disability.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of South Florida
Tampa, Florida, 33613, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Brian Bunnell
- Organization
- University of South Florida
Study Officials
- PRINCIPAL INVESTIGATOR
Brian E Bunnell, PhD
University of South Florida
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 10, 2023
First Posted
May 19, 2023
Study Start
September 1, 2022
Primary Completion
May 29, 2024
Study Completion
May 29, 2024
Last Updated
January 15, 2026
Results First Posted
January 15, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share